Stay Informed

Sign up for news & alerts

Already signed up?
Login here

take action
For every $1 states spend dollar sign on substance misuse and addiction, 94 cents go to shovel up the consequences instead of for treatment and prevention. TELL YOUR LEGISLATORS

What Can I Do?



Continuing Education
Free online courses for addiction counselors LEARN ONLINE

Get Help
Need alcohol or drug help for yourself or someone else? GET HELP

 

Recently Discovered Neurotransmitter Involved in Pleasure, Reward
August 26, 2005

Share Share Email
Email
Print
Print
SubscribeSubscribe
Research Summary

Orexin (hypocretin), a neurotransmitter recently detected by researchers, is involved in the brain's pleasure and reward system and could play a role in addiction and treatment.

Researchers at the University of Pennsylvania School of Medicine said that the findings about orexin -- previously linked to wakefulness and appetite -- could provide new avenues for addiction treatment research. Orexin seems to be involved in communication between the lateral hypothalamus region of the brain and the ventral tagmental area and nucleus accumbens.

"The lateral hypothalamus has been tied to reward and pleasure for decades, but the specific circuits and chemicals involved have been elusive," said Gary Aston-Jones, Ph.D., one of the study authors. "This is the first indication that the neuropeptide orexin is a critical element in reward-seeking and drug addiction. These results provide a novel and specific target for developing new approaches to treat addiction, obesity, and other disorders associated with dysfunctional reward processing."

The association between orexin activation and reward seeking for morphine, cocaine, and food was found to be strong in animal studies, the researchers said. Scientists were able to initiate and curb craving by introducing and blocking orexin.

"These findings indicate a new set of neurons and associated neuronal receptors that are critical in consummatory reward processing," said Aston-Jones. "This provides a new target for developing drugs to treat disorders of reward processing such as drug and alcohol addiction, smoking, and obesity."

This research appears in the Aug. 14, 2005 issue of the journal Nature.

COMMENTS ON THIS ARTICLE:
(Comments now appear first to last)

Your Turn! Post a public comment (guidelines):

Name:

Comment:
(limit 250
words)

Enter this word
(help):
Change

GUIDELINES: 
To keep this feature useful for everyone, please:

  1. Keep it clean, courteous, brief, and on-topic. Comments are for discussion of the above article, not general rants or manifestos. Serial comments intended to circumvent the 250-word limit may be deleted.

  2. Do not post promotional web links, personal information or requests for assistance (get help).

  3. Proof your comments carefully, use good spelling and punctuation, and don't use ALL CAPS. Comments are published immediately and cannot be edited.

Deceptive, slanderous and commercial posts are prohibited. We reserve the right to remove comments. (Report a comment).

Have questions or feedback? Contact us.